What Is Your Institution's Position Going To Be on Biosimilars?
作者信息
Baker Danial E
机构信息
Director, Drug Information Center, College of Pharmacy, Washington State University Spokane.
出版信息
Hosp Pharm. 2015 Jun;50(6):435-6. doi: 10.1310/hpj5006-435.
Abstract
摘要
相似文献
1
What Is Your Institution's Position Going To Be on Biosimilars?你们机构对于生物类似药的立场将会是怎样的？
Hosp Pharm. 2015 Jun;50(6):435-6. doi: 10.1310/hpj5006-435.
2
Help your institution's reputation and publish in Analytical Chemistry.提升贵机构的声誉，就在《分析化学》上发表文章。
Anal Chem. 2015 Feb 3;87(3):1421. doi: 10.1021/acs.analchem.5b00038. Epub 2015 Jan 14.
3
Formulary management. What is your institution's policy regarding formulary requests?处方集管理。贵机构对于处方集申请有何政策？
Hosp Formul. 1989 May;24(5):289.
4
Seven key points in preparing your institution's annual report.准备贵机构年度报告的七个要点。
Fund Raising Manage. 1978 Mar-Apr;9(1):54-6.
5
Criteria weighting with respect to institution's goals for faculty selection.与机构教师选拔目标相关的标准权重。
J Appl Meas. 2015;16(1):82-94.
6
Need expert help with the ADA? Look no further than your institution's own staff.在《美国残疾人法案》方面需要专家帮助？看看你所在机构自己的员工就够了。
Health Facil Manage. 1995 Jan;8(1):37.
7
Negotiating a system purchase: 8 principles for protecting your institution's interests.协商系统采购：保护机构利益的八项原则。
Healthc Exec. 1992 Jan-Feb;7(1):17-9.
8
Charting the course of your institution's joint venture.
Trustee. 1985 Oct;38(10):17-9.
9
Building on your hospital's competitive image.基于贵院的竞争形象。
Trustee. 1986 Mar;39(3):16-9.
10
Planning to keep your job.打算保住你的工作。
Comput Healthc. 1992 May;13(5):36-8.
本文引用的文献
1
Formulary Selection Criteria for Biosimilars: Considerations for US Health-System Pharmacists.生物类似药的处方集遴选标准：美国医疗系统药剂师的考量因素
Hosp Pharm. 2014 Oct;49(9):813-25. doi: 10.1310/hpj4909-813.
2
Biosimilars: Implications for health-system pharmacists.生物类似药：对卫生系统药剂师的影响。
Am J Health Syst Pharm. 2013 Nov 15;70(22):2004-17. doi: 10.2146/ajhp130119.
3
Biosimilars: part 2: potential concerns and challenges for p&t committees.生物类似药：第2部分：药品与治疗学委员会面临的潜在问题和挑战
P T. 2013 Jun;38(6):329-35.
4
Statistical methods for assessing interchangeability of biosimilars.评估生物类似药可互换性的统计方法。
Stat Med. 2013 Feb 10;32(3):442-8. doi: 10.1002/sim.5566. Epub 2012 Aug 17.
5
Biopharmaceuticals and biosimilars in psoriasis: what the dermatologist needs to know.银屑病的生物制药和生物类似药：皮肤科医生需要了解的知识。
J Am Acad Dermatol. 2012 Feb;66(2):317-22. doi: 10.1016/j.jaad.2011.08.034.
Zotero 插件